Intuitive Surgical, Inc. $ISRG Stock Purchased by Investment Partners LTD.

Investment Partners LTD. boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 105.9% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,854 shares of the medical equipment provider’s stock after purchasing an additional 1,468 shares during the quarter. Investment Partners LTD.’s holdings in Intuitive Surgical were worth $1,161,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of ISRG. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in Intuitive Surgical during the 2nd quarter worth $14,316,000. Plato Investment Management Ltd purchased a new position in shares of Intuitive Surgical in the second quarter worth about $4,315,000. Hikari Power Ltd purchased a new position in shares of Intuitive Surgical during the second quarter worth about $5,619,000. NewEdge Advisors LLC boosted its stake in shares of Intuitive Surgical by 19.1% during the second quarter. NewEdge Advisors LLC now owns 50,825 shares of the medical equipment provider’s stock valued at $20,212,000 after purchasing an additional 8,142 shares during the period. Finally, Nykredit A S purchased a new stake in shares of Intuitive Surgical in the 2nd quarter worth about $48,464,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In other news, SVP Patricia Wadors sold 1,078 shares of the firm’s stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $443.80, for a total value of $478,416.40. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Guthart sold 20,095 shares of the firm’s stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $451.61, for a total transaction of $9,075,102.95. Following the sale, the director directly owned 1,204,530 shares of the company’s stock, valued at approximately $543,977,793.30. The trade was a 1.64% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 38,778 shares of company stock valued at $16,814,967. 0.60% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Down 3.7%

Intuitive Surgical stock opened at $432.01 on Friday. The firm has a market capitalization of $149.75 billion, a P/E ratio of 52.24, a PEG ratio of 2.98 and a beta of 1.46. The firm has a fifty day moving average of $401.54 and a 200-day moving average of $434.05. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping the consensus estimate of $2.65 by $0.35. The company had revenue of $3.05 billion during the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The business’s revenue was up 21.7% on a year-over-year basis. During the same quarter last year, the firm earned $2.40 EPS. On average, research analysts expect that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the stock. KeyCorp reaffirmed an “overweight” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Royal Bank Of Canada decreased their target price on Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 21st. Raymond James Financial reiterated an “outperform” rating and set a $480.00 price target on shares of Intuitive Surgical in a report on Wednesday, October 21st. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a report on Friday, August 14th. Finally, Evercore set a $430.00 target price on shares of Intuitive Surgical in a report on Monday, July 6th. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $493.54.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.